-
SNDX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Syndax Pharmaceuticals (SNDX)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 133.24 mm | 133.24 mm | 133.24 mm | 133.24 mm | 133.24 mm | 133.24 mm |
Cash burn (monthly) | (no burn) | (no burn) | 29.86 mm | 26.77 mm | 20.77 mm | 21.57 mm |
Cash used (since last report) | n/a | n/a | 120.16 mm | 107.72 mm | 83.60 mm | 86.81 mm |
Cash remaining | n/a | n/a | 13.08 mm | 25.52 mm | 49.64 mm | 46.42 mm |
Runway (months of cash) | n/a | n/a | 0.4 | 1.0 | 2.4 | 2.2 |
13F holders | Current |
---|---|
Total holders | 214 |
Opened positions | 39 |
Closed positions | 23 |
Increased positions | 84 |
Reduced positions | 59 |
13F shares | Current |
---|---|
Total value | 1.67 tn |
Total shares | 94.11 mm |
Total puts | 692.20 k |
Total calls | 1.01 mm |
Total put/call ratio | 0.7 |
Largest owners | Shares | Value |
---|---|---|
BlackRock | 8.24 mm | $158.60 bn |
Kynam Capital Management | 5.84 mm | $112.48 bn |
Wellington Management | 4.99 mm | $95.98 bn |
Vanguard | 4.89 mm | $94.07 bn |
Eversept Partners | 4.11 mm | $79.03 bn |
Avoro Capital Advisors | 3.89 mm | $74.85 bn |
STT State Street | 3.77 mm | $72.59 bn |
Point72 Asset Management | 2.78 mm | $53.48 bn |
Access Industries | 2.60 mm | $41.19 mm |
Avidity Partners Management | 2.46 mm | $47.26 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Jun 24 | Goldan Keith A. | Common Stock | Buy | Acquire P | No | No | 20.0298 | 1,250 | 25.04 k | 52,623 |
15 May 24 | Aleksandra Rizo | Stock Options Common Stock | Grant | Acquire A | No | No | 21.94 | 35,000 | 767.90 k | 35,000 |
7 Feb 24 | Metzger Michael A | Common Stock | Grant | Acquire A | No | No | 0 | 39,000 | 0.00 | 163,909 |
7 Feb 24 | Metzger Michael A | Common Stock | Grant | Acquire A | No | No | 0 | 107,250 | 0.00 | 124,909 |
7 Feb 24 | Metzger Michael A | Stock Options Common Stock | Grant | Acquire A | No | No | 22.28 | 214,500 | 4.78 mm | 214,500 |
7 Feb 24 | William Meury | Common Stock | Grant | Acquire A | No | No | 0 | 17,000 | 0.00 | 65,000 |